RICHTER SYNDROME
Clinical trials for RICHTER SYNDROME explained in plain language.
Never miss a new study
Get alerted when new RICHTER SYNDROME trials appear
Sign up with your email to follow new studies for RICHTER SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental combo therapy targets aggressive leukemia complication
Disease control Recruiting nowThis study is testing whether adding a newer targeted drug called polatuzumab vedotin to a standard chemotherapy combination works better for people with Richter's transformation. Richter's transformation is when a slower-growing blood cancer (chronic lymphocytic leukemia) sudden…
Matched conditions: RICHTER SYNDROME
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
Personalized immune cell army joins fight against rare, Fast-Moving cancer
Disease control Recruiting nowThis study tests a three-part treatment for Richter's transformation, a fast-growing and hard-to-treat lymphoma. It combines a personalized immune cell therapy (made from the patient's own blood) with two other drugs that help the immune system attack cancer. The goal is to see i…
Matched conditions: RICHTER SYNDROME
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
New hope for aggressive cancer: trial tests powerful drug combo
Disease control Recruiting nowThis study is testing whether adding a new drug called glofitamab to standard chemotherapy (R-CHOP) works better for people with a rare and aggressive cancer called Richter syndrome. The trial will enroll 40 adults who have not yet received treatment for this condition. The main …
Matched conditions: RICHTER SYNDROME
Phase: PHASE2 • Sponsor: French Innovative Leukemia Organisation • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
First-in-Human trial tests new drug duo for aggressive blood cancer
Disease control Recruiting nowThis early-stage study is testing a new combination of two drugs, zanubrutinib and odronextamab, for patients with Richter's transformation, a fast-growing lymphoma. The main goal is to find a safe dose and understand the side effects. Researchers will also check if the treatment…
Matched conditions: RICHTER SYNDROME
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Three-Pronged attack on rare, aggressive blood cancer
Disease control Recruiting nowThis study is testing a combination of three drugs—acalabrutinib, venetoclax, and durvalumab—to see if they can help control a rare and aggressive cancer called Richter transformation. Richter transformation occurs when a slower-growing blood cancer (CLL) suddenly changes into a …
Matched conditions: RICHTER SYNDROME
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New hope for aggressive lymphoma: trial tests Dual-Attack therapy
Disease control Recruiting nowThis study is testing a new combination of two drugs, nemtabrutinib and pembrolizumab, for patients with Richter transformation, a fast-growing type of lymphoma. The goal is to see if using these drugs together is safe and can shrink or control the cancer. The trial will enroll a…
Matched conditions: RICHTER SYNDROME
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Mar 10, 2026 12:52 UTC